- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
B
BNTX
BIONTECH
108.58
1.96+1.84%Opening12:54 02/09 EST
OPEN/PREV CLOSE106.86/106.62
TODAY RANGE106.86-110.28
VOL341.97K
MARKET CAP28.13B
52 WEEK RANGE81.20-124.49
AVG VOL (3M)1.20M
% TURNOVER0.13%
TURNOVER--
P/E (TTM)-39.2255
% RANGE3.21%
EPS(TTM)-2.7681
P/E(FORWARD)-26.8258
P/B1.203
BVPS90.28
DIVIDEND--
P/S9.10
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.98B
SHARES OUTSTANDING259.03M
NEXT EARNINGS--
FREE FLOAT110.32M
LOT SIZE1
EX-DATE06/02/2022
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
Is BioNTech (BNTX) Pricing Reflecting Its Mixed Returns And Conflicting Valuation Signals?
Simply Wall St·2d ago
BioNTech Hire Signals People Focus As Oncology Plans And Valuation Attract Attention
TipRanks·5d ago
Pfizer and BioNTech Pause modRNA Shingles Ambitions
Simply Wall St·5d ago
BioNTech Adds Chief People Officer To Support Oncology Growth Plans
TipRanks·02/02 14:51
Palantir upgraded, Best Buy downgraded: Wall Street’s top analyst calls
TipRanks·02/02 13:57
BioNTech SE (BNTX) Gets a Buy from Morgan Stanley
Simply Wall St·02/02 13:15
Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus
TipRanks·02/02 12:46
Leerink downgrades BioNTech to Market Perform following ‘successful rally’
TipRanks·02/02 11:05
BioNTech downgraded to Market Perform from Outperform at Leerink
Simply Wall St·02/01 02:40
Is Goldman’s Oncology Upgrade Altering The Investment Case For BioNTech’s Pipeline-Driven Future (BNTX)?
TipRanks·01/30 11:09
Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum
Simply Wall St·01/30 05:33
BioNTech Advances Oncology Focus With BNT324 Trial And Leadership Shift
Same Industry
Name/Symbol
Change%
Price